NASDAQ:SLGL - Sol Gel Technologies News Headlines

Get Started

$7.14 +0.20 (+2.88 %)

(As of 11/13/2018 03:18 PM ET)

Previous Close$6.94

Today's Range$6.91 - $7.14

52-Week Range$5.98 - $16.48

Volume9,347 shs

Average Volume9,369 shs

Market Capitalization$132.65 million

P/E Ratio-1.42

Dividend YieldN/A

BetaN/A

Sol Gel Technologies (NASDAQ SLGL) News Headlines

Source:

Date	Headline
	Sol-Gel Technologies Announces Participation in Upcoming Investor Conference finance.yahoo.com - November 6 at 10:58 AM
	Sol-Gel Technologies Announces an Additional Collaborative Agreement for a Generic Product Candidate with Perrigo finance.yahoo.com - November 2 at 11:17 AM
	58 Stocks Moving In Thursday's Mid-Day Session www.msn.com - October 25 at 3:30 PM
	Sol Gel Technologies Ltd (SLGL) Given Average Rating of "Buy" by Brokerages www.americanbankingnews.com - October 24 at 4:46 AM
	Analyzing Global Blood Therapeutics (GBT) & Sol Gel Technologies (SLGL) www.americanbankingnews.com - October 20 at 9:06 AM
	Sol-Gel Technologies Ltd. (SLGL) Reports 50% Enrollment in Pivotal Phase III Epsolay Program for Treatment of Papulopustular Rosacea www.streetinsider.com - September 26 at 10:55 AM
	Sol-Gel Technologies Announces 50% Enrollment in Pivotal Phase III Epsolay® Program for the Treatment of Papulopustular Rosacea finance.yahoo.com - September 26 at 10:55 AM
	How Financially Strong Is Sol-Gel Technologies Ltd (NASDAQ:SLGL)? finance.yahoo.com - September 19 at 10:45 AM
	Sol-Gel Technologies Names Jonathan B. Siegel to the Board of Directors finance.yahoo.com - September 14 at 10:35 AM
	Sol-Gel Technologies Provides Program Update for TWIN for the Treatment of Acne Vulgaris finance.yahoo.com - September 5 at 10:47 AM
	6 Stocks Moving In Tuesday's After-Hours Session feeds.benzinga.com - September 4 at 6:31 PM
	Sol-Gel flat on quarterly figures www.baystreet.ca - August 8 at 10:46 AM
	Sol-Gel Technologies Reports Second Quarter 2018 Financial Results finance.yahoo.com - August 8 at 10:46 AM
	Sol-Gel launches late-stage development of Epsolay for rosacea seekingalpha.com - June 19 at 9:54 AM
	Sol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosacea finance.yahoo.com - June 19 at 9:54 AM
	Sol-Gel Technologies Announces Participation in Upcoming Investor Conferences finance.yahoo.com - May 30 at 8:58 AM
	Sol-Gel Technologies Reports First Quarter 2018 Financial Results finance.yahoo.com - May 16 at 8:23 AM
	How Do Analysts See Sol-Gel Technologies Ltd (NASDAQ:SLGL) Performing Over The Next Few Years? finance.yahoo.com - May 2 at 8:02 AM
	Global Ceramic Coatings Market Report 2017-2025 Segmented by Application, Technology and Type - ResearchAndMarkets.com www.businesswire.com - March 28 at 3:19 PM
	Sol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Website finance.yahoo.com - March 27 at 6:52 AM
	Sol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Results finance.yahoo.com - March 26 at 3:18 PM
	Acne Vulgaris Therapeutics Global Pipeline Analysis Report 2017 www.bizjournals.com - March 16 at 6:32 AM
	Dermira shares drop 66% after surprise acne clinical trial failure www.marketwatch.com - March 6 at 3:18 PM
	JMP Securities Starts Sol Gel Technologies Ltd. (SLGL) at Market Outperform www.streetinsider.com - February 26 at 3:16 PM
	Biotechs Take The Podium With The Year's 3 Best IPOs seekingalpha.com - February 22 at 3:16 PM
	Sol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meeting finance.yahoo.com - February 16 at 5:18 AM
	Sol-Gel Technologies Ltd. Announces Pricing of Initial Public Offering finance.yahoo.com - February 14 at 4:39 PM
	Sol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares finance.yahoo.com - February 14 at 4:39 PM

This page was last updated on 11/13/2018 by MarketBeat.com Staff

Featured Article: Cost of equity and a company’s balance sheet